Taking Stock Of Stocks

Bringing precision medicine to the masses

Executive director and CEO Jeremy Yee has seen Clearbridge Health grow from just two clinics in 2017 to a network of medical clinics/ centres and healthcare systems in Singapore, Malaysia, Hong Kong and the Philippines.
Executive director and CEO Jeremy Yee has seen Clearbridge Health grow from just two clinics in 2017 to a network of medical clinics/ centres and healthcare systems in Singapore, Malaysia, Hong Kong and the Philippines.ST FILE PHOTO

The Sunday Times and the Singapore Exchange's research team interview company bosses to help investors get a view of a firm's operations and strategic direction - aspects that go beyond the financials. We speak to Clearbridge Health executive director and chief executive Jeremy Yee to get his insights on the firm.

Clearbridge Health is an Asia-focused healthcare precision medicine service provider that listed on the Singapore Exchange's Catalist board in December 2017.

It was set up in 2010 in Singapore and known then as Clearbridge Accelerator. The firm invested in medical technology and incubated global deep-technology healthcare firms.

Please or to continue reading the full article. Learn more about ST PREMIUM.

Enjoy unlimited access to ST's best work

  • Exclusive stories and features on multiple devices
  • In-depth analyses and opinion pieces
  • ePaper and award-winning multimedia content
A version of this article appeared in the print edition of The Sunday Times on April 28, 2019, with the headline 'Bringing precision medicine to the masses'. Print Edition | Subscribe